Fischer Medical Ventures Limited announces unaudited financial results for Q2 FY 2026-27
Fischer Medical Ventures · Healthcare Equipment & Supplies
Key highlights
- Board approved allotment of 4,54,210 equity shares at ₹23.40 each on 17 Aug 2026, raising ₹7.97 crore from Promoter Category.
- Revisions made to comparative Q2 and H1 FY 2025 consolidated financial figures due to audit adjustments in foreign subsidiaries; no impact on annual profit or reserves.
- Unaudited standalone revenue from operations for Q2 FY 2026-27 was ₹27.62 crore; profit before tax ₹26.08 crore; EPS basic 0.31.
Original filing
Financial Results For Q2 FY26-27
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Fischer Medical Ventures
Other financial results filings this fortnight
- Financial resultsLords Mark IndustriesLord's Mark Industries Ltd submits revised Q2 & H1 FY2026 financial results
- Financial resultsMidwest EnergyMidwest Energy Limited approves Q2 FY27 results, subsidiary incorporation, share allotment
- Financial resultsBalu Forge IndustriesBalu Forge approves Q2 FY27 results and proposes preferential issue of warrants
- Financial resultsVishnu Prakash R PungliaVishnu Prakash R Punglia Ltd reports Q2 & H1 FY 2026-27 unaudited financials
- Financial resultsAshok LeylandAshok Leyland Limited announces Q2 and H1 FY 2026-27 results and interim dividend
- Financial resultsKS Smart TechnlogiesKS Smart Technologies reports Q2 & H1 FY27 results, approves subsidiary merger
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.